Know Labs Inc (KNW) Actualités

Form 8-K - Current report

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Know Labs, Inc. Announces $300K Registered Direct Offering

Know Labs, Inc. (NYSE American: KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced the...

Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that on December 10, 2024, it...

Know Labs Provides Overview of FY2024 10-K Annual Report

The Company Responds to Shareholder Concerns and Reiterates Progress and Future Plans Know Labs, Inc. (NYSE American: KNW), a leading developer...

Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in...

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 8-K - Current report

Know Labs Announces Expanded Technology Leadership in its Executive Team

Acceleration of Platform Development to Secure Multiple Strategic Partnerships Know Labs, Inc. (NYSE American: KNW), a leading developer of...

Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving

Know Labs Retains the Stanbridge Group to Secure Automotive Joint Venture Partnerships Know Labs, Inc. (NYSE American: KNW), a leading developer...

Form 8-K/A - Current report: [Amend]

Form DEF 14A - Other definitive proxy statements